These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

617 related articles for article (PubMed ID: 12067982)

  • 21. Transcriptional regulation of signal regulatory protein alpha1 inhibitory receptors by epidermal growth factor receptor signaling.
    Kapoor GS; Kapitonov D; O'Rourke DM
    Cancer Res; 2004 Sep; 64(18):6444-52. PubMed ID: 15374953
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Osteopontin-induced migration of human mammary epithelial cells involves activation of EGF receptor and multiple signal transduction pathways.
    Tuck AB; Hota C; Wilson SM; Chambers AF
    Oncogene; 2003 Feb; 22(8):1198-205. PubMed ID: 12606946
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Deficiency of kinase suppressor of Ras1 prevents oncogenic ras signaling in mice.
    Lozano J; Xing R; Cai Z; Jensen HL; Trempus C; Mark W; Cannon R; Kolesnick R
    Cancer Res; 2003 Jul; 63(14):4232-8. PubMed ID: 12874031
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Altered expression of epidermal growth factor receptor ligands in tumor promoter-treated mouse epidermis and in primary mouse skin tumors induced by an initiation-promotion protocol.
    Kiguchi K; Beltrán L; Rupp T; DiGiovanni J
    Mol Carcinog; 1998 Jun; 22(2):73-83. PubMed ID: 9655251
    [TBL] [Abstract][Full Text] [Related]  

  • 25. 12-O-tetradecanoylphorbol-13-acetate promotion of transgenic mouse epidermis coexpressing transforming growth factor-alpha and v-fos: acceleration of autonomous papilloma formation and malignant conversion via c-Ha-ras activation.
    Wang XJ; Liefer KM; Greenhalgh DA; Roop DR
    Mol Carcinog; 1999 Dec; 26(4):305-11. PubMed ID: 10569807
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Epidermal growth factor receptor activation in prostate cancer by three novel missense mutations.
    Cai CQ; Peng Y; Buckley MT; Wei J; Chen F; Liebes L; Gerald WL; Pincus MR; Osman I; Lee P
    Oncogene; 2008 May; 27(22):3201-10. PubMed ID: 18193092
    [TBL] [Abstract][Full Text] [Related]  

  • 27. EGFR, ErbB2 and Ras but not Src suppress RhoB expression while ectopic expression of RhoB antagonizes oncogene-mediated transformation.
    Jiang K; Delarue FL; Sebti SM
    Oncogene; 2004 Feb; 23(5):1136-45. PubMed ID: 14647415
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cooperation of Ha-ras and Bcl-2 during multistep skin carcinogenesis.
    Lee S; Chari NS; Kim HW; Wang X; Roop DR; Cho SH; DiGiovanni J; McDonnell TJ
    Mol Carcinog; 2007 Dec; 46(12):949-57. PubMed ID: 17538944
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Epstein-Barr virus latent membrane protein 1 (CAO) up-regulates VEGF and TGF alpha concomitant with hyperlasia, with subsequent up-regulation of p16 and MMP9.
    Stevenson D; Charalambous C; Wilson JB
    Cancer Res; 2005 Oct; 65(19):8826-35. PubMed ID: 16204053
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Diosgenin induces hypoxia-inducible factor-1 activation and angiogenesis through estrogen receptor-related phosphatidylinositol 3-kinase/Akt and p38 mitogen-activated protein kinase pathways in osteoblasts.
    Yen ML; Su JL; Chien CL; Tseng KW; Yang CY; Chen WF; Chang CC; Kuo ML
    Mol Pharmacol; 2005 Oct; 68(4):1061-73. PubMed ID: 15998873
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Akt mediates an angiogenic switch in transformed keratinocytes.
    Segrelles C; Ruiz S; Santos M; Martínez-Palacio J; Lara MF; Paramio JM
    Carcinogenesis; 2004 Jul; 25(7):1137-47. PubMed ID: 15001536
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Regulation of myeloid cell growth by distinct effectors of Ras.
    Matsuguchi T; Kraft AS
    Oncogene; 1998 Nov; 17(21):2701-9. PubMed ID: 9840934
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Reactive oxygen species regulate epidermal growth factor-induced vascular endothelial growth factor and hypoxia-inducible factor-1alpha expression through activation of AKT and P70S6K1 in human ovarian cancer cells.
    Liu LZ; Hu XW; Xia C; He J; Zhou Q; Shi X; Fang J; Jiang BH
    Free Radic Biol Med; 2006 Nov; 41(10):1521-33. PubMed ID: 17045920
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibition of gp130 signaling in breast cancer blocks constitutive activation of Stat3 and inhibits in vivo malignancy.
    Selander KS; Li L; Watson L; Merrell M; Dahmen H; Heinrich PC; Müller-Newen G; Harris KW
    Cancer Res; 2004 Oct; 64(19):6924-33. PubMed ID: 15466183
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ionizing radiation enhances matrix metalloproteinase-2 secretion and invasion of glioma cells through Src/epidermal growth factor receptor-mediated p38/Akt and phosphatidylinositol 3-kinase/Akt signaling pathways.
    Park CM; Park MJ; Kwak HJ; Lee HC; Kim MS; Lee SH; Park IC; Rhee CH; Hong SI
    Cancer Res; 2006 Sep; 66(17):8511-9. PubMed ID: 16951163
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Transgenic coexpression of v-Ha-ras and transforming growth factor alpha increases epidermal hyperproliferation and tumorigenesis and predisposes to malignant conversion via endogenous c-Ha-ras activation.
    Wang XJ; Greenhalgh DA; Roop DR
    Mol Carcinog; 2000 Mar; 27(3):200-9. PubMed ID: 10708482
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The epidermal growth factor receptor is required to maintain the proliferative population in the basal compartment of epidermal tumors.
    Hansen LA; Woodson RL; Holbus S; Strain K; Lo YC; Yuspa SH
    Cancer Res; 2000 Jul; 60(13):3328-32. PubMed ID: 10910032
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Adenoviral-mediated expression of a kinase-dead mutant of Akt induces apoptosis selectively in tumor cells and suppresses tumor growth in mice.
    Jetzt A; Howe JA; Horn MT; Maxwell E; Yin Z; Johnson D; Kumar CC
    Cancer Res; 2003 Oct; 63(20):6697-706. PubMed ID: 14583464
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Activation of the epidermal growth factor receptor by skin tumor promoters and in skin tumors from SENCAR mice.
    Xian W; Kiguchi K; Imamoto A; Rupp T; Zilberstein A; DiGiovanni J
    Cell Growth Differ; 1995 Nov; 6(11):1447-55. PubMed ID: 8562483
    [TBL] [Abstract][Full Text] [Related]  

  • 40. c-Ha-ras gene mutation and activation precede pathological changes in DMBA-induced in vivo carcinogenesis.
    Kwong YY; Husain Z; Biswas DK
    Oncogene; 1992 Aug; 7(8):1481-9. PubMed ID: 1630811
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 31.